{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:35:16Z","timestamp":1790087716886,"version":"4.0.1"},"reference-count":25,"publisher":"Japan Atherosclerosis Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.5551\/jat.65336","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:13:58Z","timestamp":1740762838000},"page":"1053-1070","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Trial"],"prefix":"10.5551","volume":"32","author":[{"given":"Shizuya","family":"Yamashita","sequence":"first","affiliation":[{"name":"Department of Cardiology, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yokota","sequence":"additional","affiliation":[{"name":"Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Morikawa-Isogai","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuki","family":"Kitamoto","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Rumana N, Kita Y, Turin TC, Murakami Y, Sugihara H, Morita Y, Tomioka N, Okayama A, Nakamura Y, Abbott RD, Ueshima H: Trend of increase in the incidence of acute myocardial infarction in a Japanese population. Takashima AMI Registry, 1990-2001. Am J Epidemiol, 2008; 167: 1358-1364","DOI":"10.1093\/aje\/kwn064"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kitamura A, Iso H, Iida M, Naito Y, Sato S, Jacobs DR, Nakamura M, Shimamoto T, Komachi Y: Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med, 2002; 112: 104-109","DOI":"10.1016\/S0002-9343(01)01053-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H, MIYAGI-AMI Study Investigators: Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the Miyagi-AMI Registry Study. Circ J, 2010; 74: 93-100","DOI":"10.1253\/circj.CJ-09-0619"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nishiyama S, Watanabe T, Arimoto T, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Nitobe J, Shibata Y, Konta T, Kawata S, Kato T, Fukao A, Kubota I: Trends in coronary risk factors among patients with acute myocardial infarction over the last decade: the Yamagata AMI Registry. J Atheroscler Thromb, 2010; 17: 989-998","DOI":"10.5551\/jat.4671"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M: High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs. J Atheroscler Thromb, 2015; 22: 1287-1304","DOI":"10.5551\/jat.28852"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sugiyama D, Okamura T, Watanabe M, Higashiyama A, Okuda N, Nakamura Y, Hozawa A, Kita Y, Kadota A, Murakami Y, Miyamatsu N, Ohkubo T, Hayakawa T, Miyamoto Y, Miura K, Okayama A, Ueshima H; NIPPON DATA 80\/90 Research Group: Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study. J Atheroscler Thromb, 2015; 22: 95-107","DOI":"10.5551\/jat.25908"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tanabe N, Iso H, Okada K, Nakamura Y, Harada A, Ohashi Y, Ando T, Ueshima H; Japan Arteriosclerosis Longitudinal Study Group: Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events -the JALS-ECC-. Circ J, 2010; 74: 1346-1356","DOI":"10.1253\/circj.CJ-09-0861"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nagasawa SY, Okamura T, Iso H, Tamakoshi A, Yamada M, Watanabe M, Murakami Y, Miura K, Ueshima H: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group. J Am Heart Assoc, 2012; 1: e001974","DOI":"10.1161\/JAHA.112.001974"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sugiyama D, Turin TC, Yeasmin F, Rumana N, Watanabe M, Higashiyama A, Takegami M, Kokubo Y, Okamura T, Miyamoto Y: Hypercholesterolemia and Lifetime Risk of Coronary Heart Disease in the General Japanese Population: Results from the Suita Cohort Study. J Atheroscler Thromb, 2020; 27: 60-70","DOI":"10.5551\/jat.49098"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E and Sabatine MS: Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA, 2016; 316: 1289-1297","DOI":"10.1001\/jama.2016.13985"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, Ferencik M: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 2022; 328: 754-771","DOI":"10.1001\/jama.2022.12138"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR; DA VINCI study: EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. Eur J Prev Cardiol, 2021; 28: 1279-1289","DOI":"10.1093\/eurjpc\/zwaa047"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mitani H, Suzuki K, Ako J, Iekushi K, Majewska R, Touzeni S, Yamashita S: Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan. J Atheroscler Thromb, 2023; 30: 1622-1634","DOI":"10.5551\/jat.63940"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ahmad Z: Statin intolerance. Am J Cardiol, 2014; 113: 1765-1771","DOI":"10.1016\/j.amjcard.2014.02.033"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Goldberg AC, Leiter LA, Stroes ESG, Baum SJ, Hanselman JC, Bloedon LT, Lalwani ND, Patel PM, Zhao X, Duell PB: Effect of Bempedoic Acid vs. Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. JAMA, 2019; 322: 1780-1788","DOI":"10.1001\/jama.2019.16585"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators: Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. N Engl J Med, 2023; 388: 1353-1364","DOI":"10.1056\/NEJMoa2215024"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, Leiter LA: Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. Atherosclerosis, 2018; 277: 195-203","DOI":"10.1016\/j.atherosclerosis.2018.06.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, Robinson PL, Ballantyne CM: CLEAR Harmony Trial. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. N Engl J Med, 2019, 380: 1022-1032","DOI":"10.1056\/NEJMoa1803917"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Laufs U, Banach M, Mancini GBJ, Gaudet D, Bloedon LT, Sterling LR, Kelly S, Stroes ESG: Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. J Am Heart Assoc, 2019; 8: e011662","DOI":"10.1161\/JAHA.118.011662"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ballantyne CM, McKenney JM, MacDougall DE, Margulies JR, Robinson PL, Hanselman JC, Lalwani ND: Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy. Am J Cardiol, 2016; 117: 1928-1933","DOI":"10.1016\/j.amjcard.2016.03.043"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Thompson PD, MacDougall DE, Newton RS, Margulies JR, Hanselman JC, Orloff DG, McKenney JM, Ballantyne CM: Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance. J Clin Lipidol, 2016; 10: 556-567","DOI":"10.1016\/j.jacl.2015.12.025"},{"key":"23","unstructured":"23) Kajinami K, Tsukamoto K, Kiba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda C, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kanayama J, Kuriyama A, Tanaka R, Hirata A: Medical guidelines for statin intolerance 2018. Available from https: \/\/www.j-athero.org\/jp\/wp-content\/uploads\/publications\/pdf\/statin_intolerance_2018.pdf"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pinkosky SL, Newton RS, Day EA, Ford RJ, Lhotak S, Austin RC, Birch CM, Smith BK, Filippov S, Groot PHE, Steinberg GR, Lalwani ND: Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis. Nat Commun, 2016; 7: 13457","DOI":"10.1038\/ncomms13457"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Amore BM, MacDougall DE, Hanselman JC, Emery MG: Phase 1, Single- and Multiple-Ascending-Dose, Food-Effect, and East Asian Subject Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Bempedoic Acid, a Selective Inhibitor of Adenosine Triphosphate Citrate Lyase. Clin Pharmacol Drug Dev, 2023; 12: 1022-1035","DOI":"10.1002\/cpdd.1297"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/8\/32_65336\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:25:03Z","timestamp":1754108703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/8\/32_65336\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65336","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"65336"}}